Ryan Widau to Stomach Neoplasms
This is a "connection" page, showing publications Ryan Widau has written about Stomach Neoplasms.
Connection Strength
0.035
-
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial. Lancet Oncol. 2019 08; 20(8):1109-1123.
Score: 0.035